Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 5:24 pm Sale | 13G | SIGHT SCIENCES INC SGHT | KCK LTD. | 4,646,866 9.5% | -129,366 (-2.71%) | View |
| 2024-02-13 6:52 pm Purchase | 13G | SIGHT SCIENCES INC SGHT | BANK OF AMERICA CORP BAC | 3,174,134 6.5% | 3,174,134 (New Position) | View |
| 2024-02-07 3:01 pm Purchase | 13G | SIGHT SCIENCES INC SGHT | UBS Group AG UBS | 2,879,863 5.9% | 2,879,863 (New Position) | View |
| 2024-01-10 4:15 pm Sale | 13G | SIGHT SCIENCES INC SGHT | D1 Capital Partners L.P. | 0 0% | -5,852,036 (Position Closed) | View |
| 2023-12-01 4:05 pm Purchase | 13D | SIGHT SCIENCES INC SGHT | Encrantz Staffan | 6,203,432 12.7% | 997,056 (+19.15%) | View |
| 2023-02-14 4:06 pm Purchase | 13G | SIGHT SCIENCES INC SGHT | Badawi Paul | 5,691,953 11.8% | 294,281 (+5.45%) | View |
| 2023-02-14 11:01 am Sale | 13G | SIGHT SCIENCES INC SGHT | HEP Partners LLC | 620,574 1.3% | -3,852,302 (-86.13%) | View |
| 2023-02-13 4:18 pm Purchase | 13G | SIGHT SCIENCES INC SGHT | KCK LTD. | 4,776,232 9.9% | 4,776,232 (New Position) | View |
| 2022-05-19 10:32 am Purchase | 13D | SIGHT SCIENCES INC SGHT | Encrantz Staffan | 5,206,376 10.9% | 551,802 (+11.86%) | View |
| 2022-04-15 7:15 pm Sale | 13D | SIGHT SCIENCES INC SGHT | SHD GP II LLC | 472,107 0.99% | -1,943,867 (-80.46%) | View |
| 2022-02-14 5:05 pm Purchase | 13G | SIGHT SCIENCES INC SGHT | Selnick Jesse | 2,434,984 5.1% | 2,434,984 (New Position) | View |
| 2022-02-14 5:00 pm Purchase | 13G | SIGHT SCIENCES INC SGHT | Badawi Paul | 5,397,672 11.4% | 5,397,672 (New Position) | View |
| 2022-02-14 3:35 pm Purchase | 13G | SIGHT SCIENCES INC SGHT | HEP Partners LLC | 4,472,876 9.5% | 4,472,876 (New Position) | View |
| 2021-12-10 4:31 pm Purchase | 13D | SIGHT SCIENCES INC SGHT | Encrantz Staffan | 4,654,574 9.8% | 4,654,574 (New Position) | View |
| 2021-08-10 4:28 pm Purchase | 13G | SIGHT SCIENCES INC SGHT | D1 Capital Partners L.P. | 5,852,036 12.5% | 5,852,036 (New Position) | View |
| 2021-07-26 8:23 pm Purchase | 13D | SIGHT SCIENCES INC SGHT | SHD GP II LLC | 2,415,974 5.17% | 2,415,974 (New Position) | View |